In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.
about
Low dose nicotine and antagonism of β2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in miceStimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice.In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers.Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys.Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers.Brain β2*-nicotinic acetylcholine receptor occupancy after use of a nicotine inhaler.Imaging changes in synaptic acetylcholine availability in living human subjects.Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding.Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers.Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomographyImaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain.
P2860
Q28484969-E7D3C36D-E9F1-4CD0-A8B6-DCBAEA2E6580Q30487535-CB69FE2D-1EAA-4918-AA32-8D0D29D74680Q33605318-1BE8528B-38B9-467D-A42B-AFE3005A63E8Q34329011-4BAA6194-7ECB-4161-9571-C5DB2EA90130Q34472238-AA81AC10-5357-4BD6-A27D-32B7382829F5Q36076416-4F3E0D85-316B-42F1-93F7-30792A932FF0Q36433744-66206A5B-0F70-401A-BDA4-400C10A22978Q36989300-D31A7860-C4A0-4AA4-A688-3647B8F9E272Q37000214-75EF6735-6C7C-4B75-B512-81138DBCE7E5Q37397312-20DE58BE-5643-497D-9540-D88FC10BCB12Q38244707-76F77D9C-2341-46C1-A121-432A28924017Q38840893-05A6E431-371A-4060-834A-87C039735E50Q48127778-84D57140-AFBB-4B4D-9896-B66C5451FA9A
P2860
In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.
@en
In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.
@nl
type
label
In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.
@en
In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.
@nl
prefLabel
In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.
@en
In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.
@nl
P2093
P1433
P1476
In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.
@en
P2093
P304
P356
10.1097/00001756-199807130-00030
P577
1998-07-01T00:00:00Z